Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-07

Clinical Trial Update: The Lighthouse Tenofovir Cohort Study

View source ↗

Summary

An update on the Lighthouse Tenofovir Cohort Study investigating effects in chronic renal disease; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Lighthouse Trust | Conditions: Chronic Renal Disease | Status: UNKNOWN